8-K
Current Report
Protalix BioTherapeutics, Inc. Filed Acc 0001144204-12-040015
Executive or director change · Bylaws or fiscal year change
- Item 5.02 Departure or appointment of directors or officers
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading v318898_8k.htm…